toronto april 30 2015 globe newswir profound medic inc profound medic devic compani develop commerci uniqu minim invas treatment prostat cancer announc today profound enter definit agreement date april 29 2015 mira iv acquisit corp mira tsxv mryp capit pool compani trade tsx ventur exchang pursuant whollyown subsidiari mira amalgam profound complet arm length qualifi transact transact accord polici tsx ventur exchang tsxv transact constitut revers takeov mira follow holder common share profound includ common share issu holder subscript receipt issu privat placement describ hold major outstand common share mira amalgam structur threecorn amalgam result amalgam corpor becom whollyown subsidiari mira time complet transact follow complet transact mira chang name profound medic corp connect transact profound complet today privat placement subscript receipt subscript receipt gross proceed approxim 24 million led gmp secur lp cormark secur inc includ bloom burton co macki research capit corpor subscript receipt issu privat placement exchang one common share capit profound upon satisfact certain condit relat transact expect close may 21 2015 financ transact conjunct contempl mira transact highlight transform year bring compani one step closer make signific differ futur men prostat health say steve plymal ceo profound medic inc appreci interest confid invest communiti technolog anticip offer subscript receipt januari 27 2015 profound close bridg financ transact genesi ventur ii lp genesi bdc capit inc bdc two sharehold profound aggreg gross proceed 1500000 assum transact close may 21 2015 secur convert note includ accru interest thereund automat convert common share profound price 150 per common share equival issu price per subscript receipt approxim 346000 common share 692000 common share profound respect separ genesi bdc particip privat placement addit aggreg invest 4800000 profound also announc connect privat placement transact knight therapeut inc knight tsxgud provid secur loan 4000000 initi period four year interest rate 15 per annum payment interest princip defer june 30 2017 addit profound also enter distribut licens suppli agreement knight pursuant knight act exclus distributor profound tulsapro system canada initi ten year term renew success ten year term either parti transact fee connect arrang profound agre issu knight 4 equiti profound give effect transact profound also grant knight right nomin one member board director connect loan transact expect knight nomine elect board director jonathan ross goodman knight presid ceo separ knight particip privat placement addit invest approxim 2000000 profound technolog transurethr ultrasound ablat tulsa investig phase devic use minim invas treatment local prostat cancer realtim mriguid ultrasound procedur ablat whole gland insideout singl session potenti faster patient recoveri signific reduc side effect enabl patient partner quick resum qualiti life tulsapro investig devic yet approv commerci use profound recent complet 12 month follow 30 patient tulsa safeti feasibl trial process analys data upon complet qualifi transact mira profound access privat placement proceed commenc pivot clinic trial 110 patient support pend european canadian tulsapro product launch profound medic incprofound medic medic devic compani develop uniqu minim invas treatment ablat prostat gland profound novel technolog combin mri technolog ultrasound thermal energi deliv via transurethr approach investig method prostat ablat therapi provid high accur precis treatment within prostat short time span allow fast patient recoveri potenti technolog current assess clinic trial inform visit profoundmedicalcomthi press releas constitut offer sell solicit offer buy secur jurisdict secur refer herein regist us secur act 1933 1933 act may offer sold inth unit statesor us person absenc registr exempt registr requir 1933 act distribut us newswir servic dissemin unit state failur compli restrict may constitut violat us secur law notic regard forwardlook statement releas includ forwardlook statement regard profound busi may includ limit statement respect complet transact term transact intend complet use net proceed privat placement often alway forwardlook statement identifi use word plan expect expect schedul intend contempl anticip believ propos variat includ negat variat word phrase state certain action event result may could would might taken occur achiev statement base current expect manag entiti forwardlook event circumst discuss releas includ complet transact may occur certain specifi date could differ materi result known unknown risk factor uncertainti affect compani includ risk regard medic devic industri failur obtain regulatori sharehold approv econom factor equiti market general risk associ growth competitionalthough profound attempt identifi import factor could caus actual action event result differ materi describ forwardlook statement may factor caus action event result differ anticip estim intend forwardlook statement guarante except requir applic secur law forwardlook statement speak date made profound undertak oblig public updat revis forwardlook statement whether result new inform futur event otherwis requir law steve plymal ceoprofound medic incsplymaleprofoundmedicalcomt 6474761350 